Michele Washington focuses her practice on the preparation and prosecution of patent applications in the life sciences. Her experience covers a wide range of technologies, including cellular and molecular biology, biochemistry, biological therapies, antibody technology, immunotherapy, agriculture biotechnology, and medical devices. Michele’s specific experience includes prosecuting worldwide patent portfolios; and performing freedom to operate, patentability and invalidity analyses. In addition to patent prosecution, Michele also has experience preparing and prosecuting trademark applications, as well as assisting clients in trademark disputes.
University of Denver, Sturm College of Law (J.D., 2014)
Irving P. Andrews Award for Outstanding Law Graduate
Baylor College of Medicine, Graduate School of Biomedical Sciences (Ph.D., Department of Molecular and Cellular Biology, 2010)
Dissertation: "Targets of Vitamin D Receptor Action in Prostate Cancer Cells"
The Colorado College (B.A., Biology, 2003)
Minor in Spanish
American Intellectual Property Law Association
Colorado Intellectual Property American Inn of Court
"ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts," Co-Author, 2015 Cell Death and Disease 6, e1836 (2015)
"Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy," Co-Author, 2011 Cancer 117(19):4424-38 (2011)
"1a,25-Dihydroxyvitamin D3 Inhibits C4-2 Prostate Cancer Cell Growth via a Retinoblastoma Protein (Rb)-Independent G1 Arrest," Co-Author, 2010 The Prostate 71(1):98-110 (2010)
"1a,25-Dihydroxyvitamin D3 Inhibits Growth of VCaP Prostate Cancer Cells Despite Iducing the Growth-Promoting TMPRSS2:ERG Gene Fusion," Co-Author, 2010 Endocrinology 151(4):1409-1417 (2010)
"Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor," Co-Author, 2005 Molecular Endocrinology 19(6):1646-1653 (2005)
"Sulindac Sulfide Inhibits Epidermal Growth Factor-inducted Phosphorylation of Extracellular-regulated Kinase 1/2 and Bad in Human Colon Cancer Cells," Co-Author, 2003 Cancer Research 63:616-620 (2003)